Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

RiDYMO® develops a cyclic peptide targeting the "undruggable" β-catenin in just two months

The Wnt/β-catenin pathway plays a crucial role in various biological functions and is implicated in multiple cancers[1-3]. Despite its importance as a therapeutic target[4-7], β-catenin has long been considered "undruggable" due to its flat protein...

NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price

cure of diabetes, announce the successful completion of the initial closing of $500,000 of the previously announced $1 million financing between NLS and an accredited investor under a securities purchase agreement dated December 4, 2024, with the...

Cardurion Pharmaceuticals has named Charlotte Newman as Chief Business Officer

as senior vice president of portfolio leadership and joining the company as vice president of its rare disease program in 2018. As CBO, she was responsible for the strategy and execution of Agios’ portfolio as it evolved to focus on potential first...

PBS Biotech Secures $17M and Expands Leadership to Accelerate Next-Gen Cell Therapies

Biotech ("PBS"), a provider of innovative single-use bioreactor systems and bioprocess development services, has secured $17 million in follow-on growth capital from Avego Management, LLC ("Avego") and BroadOak Capital Partners ("BroadOak"). This...

Axio BioPharma Partners with eMBR Genomics to Manufacture and Distribute Proprietary MKLP1 Pro™ Antibodies

In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 Pro™ antibodies, KIF23 gene – the same tools used by the world's leading Midbody Remnants (MBRs) researchers. This strategic...

Strategic Expansion Expands Fusion Orthopedics' Foot & Ankle Reach

sharpness OVER 50 uses. Keeping with Fusion’s aim to provide patient specific solutions, the Revolution EPS also features 180-Degree Lockable Swivel Struts which give the surgeon the ability to attach one ring plate to another at any reasonable...

Spyre Therapeutics Announces Inducement Award Grants

that Spyre's independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase 21,000 shares of common stock of Spyre to one non-executive employee as an equity inducement award under the Spyre...

Genesis Medtech secures Chinese approval for its groundbreaking 90° articulation powered surgical stapler, setting new standards in precision surgery

thoracic surgeries. Colorectal cancer is one of the top three cancers worldwide, affecting millions of people each year.[1] Surgical resection of the tumor remains the primary treatment for low rectal cancer but surgeons face significant challenges...

Eden has launched the world’s first compounded GLP-1 prescription gummy, offering a novel and convenient approach to weight management treatment

Eden has launched the world's first compounded semaglutide gummy. Designed to deliver the benefits of GLP-1 medications in a convenient, needle-free format, this innovative format reimagines how individuals approach GLP-1 programs in the United...

"Fresenius Kabi expands its U.S. pharma portfolio with the launch of Epinephrine Injection, USP

that Epinephrine Injection, USP, is now available in the United States as the first generic version of Epinephrine in a 1mg/1mL vial for U.S. customers. Epinephrine Injection, USP is a prescription medicine used to increase mean arterial blood...

Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements

treating lupus. Lupus is a chronic autoimmune disease that afflicts millions of patients worldwide, primarily women aged 15-45. Lupus nephritis can severely affect quality of life and result in kidney failure if not properly managed. This...

ADC Therapeutics shares promising initial LOTIS-7 trial data on ZYNLONTA® combined with a bispecific antibody for relapsed/refractory DLBCL.

leader and pioneer in the field of antibody drug conjugates (ADCs), announced positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of ZYNLONTA® in combination with the bispecific antibody...

MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee

innovations. As an honoree, Nicole will be celebrated at a dinner at The Edison Ballroom in New York City on February 11, 2025. For more information about MM+M's 40 Under 40 program, visit www.mmm40under40.com. About Petauri: Petauri is a...

Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer

that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecule, PLT012, for treating liver and intrahepatic bile duct cancer (HCC/ICCA). Achieved in November 2024, this designation marks a crucial...

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

diabetic indications. The newly completed study builds upon a previous DIO study in which BLX-7006 demonstrated a promising 15.6 % weight loss. In the expanded study, BLX-7006 achieved a substantial 29% weight loss, attributed to evaluating higher...

UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors

nearly 20 years of medical device experience, including serving as the chief operating officer of Axonics for more than 10 years where he played a critical role in implementing lean operations and compliant quality systems that helped to pave the...

Children’s Hospital Los Angeles completes its 100th retinal gene therapy procedure, advancing pediatric vision care.

with poor vision in dim light and night blindness. Ultimately, patients lose all of their sight by middle age. But since 2018, Dr. Nagiel and his team at the Vision Center of Children’s Hospital Los Angeles have been treating these patients with a...

Leqembi® approved in Mexico

Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of early Alzheimer's disease (AD)1. Leqembi selectively binds to soluble amyloid-beta (Aβ) aggregates (protofibrils2), as well as insoluble Aβ aggregates...

Phanes Therapeutics' PT217 receives FDA Fast Track Designation for neuroendocrine prostate cancer (NEPC)

in oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PT217 for the treatment of patients with metastatic de novo or treatment-emergent neuroendocrine prostate cancer (NEPC). This is the...

SciTech Development reveals promising Phase 1A trial results for T-cell non-Hodgkin lymphoma therapy

company focused on advancements in cancer treatment, is excited to share promising updates from its clinical trial of ST-001 nanoFenretinide (ST-001). Preliminary Trial Findings: Preliminary data from the accelerated Phase 1a trial in patients with...